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Abstract
Pathogenesis of the inflammatory bowel disease (IBD) involves the combination of immunological and inflammatory factors. 
IBD is associated with several extra-intestinal manifestations. The exact underlying bridge between the probable cardiac 
diseases in IBD patients is undetermined. Trigonelline is an alkaloid with several therapeutic potential properties. In this 
study, we aimed to assess the probable underlying mechanisms of this comorbidity as well as protective effect of trigonel-
line focusing inflammatory response and oxidative state in mouse model of colitis. Dextran sodium sulfate (DSS) was used 
for induction of colitis in mice. Trigonelline (10, 50 and 100 mg/kg) was administrated via intraperitoneal rout (i.p.) for 14 
continuous days. Heart, intestine and serum samples were taken for assessment of total antioxidant capacity, malondialdehyde 
(MDA), gene expressions of inflammatory markers including tumor necrosis factor alpha (Tnf-α), interleukin 1-beta (Il/1β), 
toll- like receptor 4 (Tlr4) as well as for evaluation of histopathological alterations. Results demonstrated that trigonelline 
effectively attenuated the cellular/molecular and histopathological adverse effects of colitis in the intestine and heart tis-
sues. In this regards, we found that trigonelline decreased the MDA level, attenuated the expression of Tnf-α, Il/1β and, Tlr4 
as well as modulated the histopathological alterations in the intestine. Furthermore, trigonelline increased the antioxidant 
capacity in the related experimental groups. We concluded that IBD (colitis) is associated with comorbid cellular/molecular 
modifications in the heart and for the first time, we found that trigonelline has potential therapeutic effects (at least partially) 
to attenuate the cardiac manifestations of the colitis.
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Introduction
Inflammatory bowel disease (IBD) is categorized into ulcer-
ative colitis (UC) and Crohn’s disease (CD), and leads to 
long-term and sometimes irreversible disturbances of gas-
trointestinal structure and function (Xavier and Podolsky 
2007; Blumberg and Strober 2001). The common hypothesis 
on the cause of IBD is the combination of immunological 
and inflammatory factors (Bouma and Strober 2003). In this 
regards, it has been determined that gastrointestinal micro-
flora acts as initiators for activation of the inflammation in the 
intestine (Pavli et al. 1996). In addition, ectopic activation of 
the immune system has a critical role in the IBD pathogenesis 
such that immunosuppressant such as steroids and azathio-
prine are effective in treatment of IBD (Danese et al. 2005).
It has been well known that IBD leads to several extra-
intestinal complications, including eye, kidney, liver, 
muscle and pulmonary complications. There is an ample 
evidence showing that IBD patients are at high risk of 
developing cardiovascular diseases (Thapa et al. 2015; 
Schicho et al. 2015). In this concept, inflammatory mark-
ers which are increased in patients with IBD have a direct 
association with cardiovascular diseases. Previous stud-
ies have demonstrated that inflammation involves in the 
pathogenesis of both IBD and cardiovascular disorders 
(Danese et al. 2005). However, current evidences are insuf-
ficient to confirm that IBD patients are at increased risk 
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of developing cardiovascular disorders (McKenzie et al. 
1996). Thus, further studies warranted to clarify possible 
pathogenic links between cardiovascular disorders with 
IBD.
The intestinal mucosa has receptors called toll- like 
receptor 4 (Tlr4) identifying bacteria-derived LPS. The 
activation of Tlr4 activates the NF-κB signaling pathway 
resulting in the production of cytokines and inflammatory 
markers such as Tnf-α and Il-1β (Laird et al. 2009). Tnf-
α and Il-1β increase the permeability of vasculature as 
well as gut mucosa leading to migration of LPS from the 
intestinal lumen to the mucosa and subsequently to the cir-
culation (Al-Sadi and Ma 2007; Popivanova et al. 2008).
Trigonelline is an alkaloid present in fenugreek and cof-
fee. Various pharmacological effects have been reported 
for trigonelline including blood glucose lowering, anti-
hyperlipidemic, antihyperglycemic and antiinflamma-
tory effects (Antonisamy et al. 2016; Zhou et al. 2017). It 
has been determined that trigonelline exerted a potential 
therapeutic effect on gastrointestinal ulcers via reduction 
of inflammation as well as potentiation of antioxidant 
capacity (Antonisamy et al. 2016). Literature suggested 
that trigonelline potently reduced the levels of Il-6, Il-1β, 
and Tnf-α (Yoshinari et al. 2013; Zhou et al. 2017).
Considering there are evidences which demonstrated 
that (1) IBD patients are at high risk for developing cardiac 
disorders, (2) trigonelline possessed various pharmacologi-
cal properties in inflammatory states, in the current study, 
we aimed to examine the possible protective effect of trigo-
nelline against cardiac disorders which are comorbid with 
the IBD in the mice model of IBD disease induced by DSS.
Materials and methods
Chemicals
Trigonelline, dextran sulfate sodium (DSS) (MW 
36,000–50,000) were purchased from the Sigma (Sigma, 
USA).
Animals
Seventy-two male NMRI mice (20–25 g) (Pasteur Institute 
of Iran, Tehran, Iran) were used in this study. Animals were 
kept under standard laboratory conditions. All procedures 
were carried out in accordance with the National Institutes 
of Health (NIH) Guideline for the Care and Use of Labo-
ratory Animals (NIH publication #80–23) and institutional 
guideline for animal care and use (Shahrekord University of 
Medical Sciences, SKUMS) with ethical code: IR.SKUMS.
REC.1395.302.
Induction of experimental IBD
To induce chronic experimental colitis, dextran sodium sul-
fate (DSS) was dissolved in drinking water (concentration 
of 5%). Mice were given DSS solution for 7 days, in four 
cycles. The intervals between cycles are 10 days (Kojou-
haroff et al. 1997).
Study design
Mice were divided into nine experimental groups and treated 
continuously for 14 days (Fig. 1). Groups were included as 
follows: group 1: IBD was induced and received normal 
saline for 14 days, group 2: control group (without colitis) 
received saline for 14 days, groups 3–5: intact mice (without 
colitis) received trigonelline at doses of 10, 50 and 100 mg/
kg for 14 days, groups 6–8: experimental colitis mice (IBD 
was induced) received trigonelline at doses of 10, 50 and 
100 mg/kg for 14 days. Treatments were begun at 58th day 
of the study for 14 constant days. At the end of the study 
(day of 72), mice were killed under light ether anesthesia, 
and heart, colon, and blood samples were immediately col-
lected (Liu et al. 2018). We have collected our samples from 
the distal section of colon (Swidsinski et al. 2005) and mid-
part of the heart (Gabriels et al. 2012).
Trigonelline was dissolved in the saline and injected via 
the intraperitoneal (ip) route. Dose and time of drug admin-
istration were chosen according to our pilot study as well 
as previous studies (Antonisamy et al. 2016, Mirzaie et al. 
Fig. 1  Schematic of the study design
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2016). Mice were divided into nine groups (n = 8). All trial 
groups involved eight mice and we tried to minimize the use 
of animals and to improve their well-being.
Histopathological examination
Colon and heart samples were dissected out and then fixed in 
10% formaldehyde and embedded in paraffin. For each sam-
ple, 5-μm sections from the paraffin blocks were obtained 
and processed for routine hematoxylin–eosin (H&E) stain-
ing. Of each experimental group, eight samples (n = 8) were 
prepared for histopathological assessment. Five sections 
from each sample were examined for grading.
The microscopic scoring for colon tissue was performed 
as follows: Epithelium (E): 0, normal morphology; 1, loss 
of goblet cells; 2, loss of goblet cells in large areas; 3, loss 
of crypts; 4, loss of crypts in large areas. Infiltration (I): 
0, no infiltrate; 1, infiltrate around crypt basis; 2, infiltrate 
reaching to L. muscularis mucosae; 3, extensive infiltration 
reaching the L. muscularis mucosae and thickening of the 
mucosa with abundant edema; 4, infiltration of the L. sub-
mucosa. The total histological score represents the sum of 
the epithelium and infiltration scores (total score  =  E  +  I) 
(Haj-Mirzaian et al. 2017; Amini-Khoei et al. 2019).
Microscopic grading for heart samples was performed 
according to the method described previously. The extent of 
cardiac inflammation was scored as follows: minimal (grade 
1) changes involved 1–10% of the section; mild (grade 2) 
involved 11–40%; moderate (grade 3) involved 41–80%; 
and severe (grade 4) involved 81–100% (Zhang et al. 2007; 
Nyska et al. 2004).
Determination of gene expression
RNA extraction was carried out using RNX-plus isolation 
reagent according to the manufacturer’s instructions. RNA 
was quantified using Nanodrop technologies. Alterations 
in the mRNA expression of genes were also performed by 
Real-time polymerase chain reaction (PCR). After reverse 
transcription of mRNA with PrimeScript RT reagent kit 
(Takara) according to the manufacturer’s instruction, the 
qRT-PCR experiment was done on a light cycler apparatus 
(Rotor gene Diagnostics) using the SYBR Premix Ex Taq 
technology (Takara). The thermal cycling program profile 
was 95 °C for 30 s and followed by 45 cycles of denatura-
tion for 5 s at 95 °C, and annealing step for 15 s at 60 °C 
and extension for 15 s at 72 °C. Melting curve analysis was 
applied to confirm whether all primers yield a single PCR 
product. Histone H2A variant, H2afz, was amplified as a 
normalizer and fold changes in expression of each target 
mRNA relative to H2afz were calculated based on  2−ΔΔCt 
relative expression formula, as described earlier. The primer 
sequences are demonstrated in Table 1.
Determination of total antioxidant capacity
Ferric reducing/antioxidant power (FRAP) assay was per-
formed to measure total antioxidant capacity in the serum, 
colon and heart samples according to the previous stud-
ies. In brief, the antioxidant power of samples was deter-
mined by measuring its ability to reduce Fe3+ to Fe2+ with 
FRAP (ferric reducing antioxidant power) test. FeSO4 
(100–1000 µM concentration range) was used as a standard 
in FRAP assay (Rahnama et al. 2015; Luque-Sierra et al. 
2018).
Measurement of the malondialdehyde (MDA)
The malondialdehyde (MDA) concentration in the serum, 
colon and heart samples was measured spectrophotometri-
cally as described previously (Zou et al. 2016; Wong et al. 
1987). Briefly, trichloroacetic acid and a TBARS reagent 
were added to the supernatant, then mixed and incubated in 
boiling water for 90 min. After cooling on ice, the samples 
were centrifuged at 1000g for 10 min, and the absorbance 
of the supernatant was read at 532 nm. The TBARS results 
were expressed as MDA equivalents using tetraethoxypro-
pane as standard.
Statistical analysis
Comparison between the groups was analyzed using one-
way ANOVA followed by Tukey’s post hoc test in the 
GraphPad Prism software (version 7). p <  0.05 was consid-
ered as statistically significant.
Table 1  Primer sequences Primer Forward sequence Reverse sequence
H2afz TCA TCG ACA CCT GAA ATC TAGGA AGG GGT GAT ACG CTT TAC CTTTA 
TNF-α CTG AAC TTC GGG GTG ATC GG GGC TTG TCA CTC GAA TTT TGAGA 
Il-1β GAA ATG CCA CCT TTT GAC AGTG TGG ATG CTC TCA TCA GGA CAG 
Tlr4 ATG GCA TGG CTT ACA CCA CC GAG GCC AAT TTT GTC TCC ACA 
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Results
Trigonelline increased the antioxidant capacity 
in the intestine, heart and serum samples
Findings (Fig. 2) showed that experimental colitis signifi-
cantly decreased the antioxidant capacity in the intestine 
(p < 0.01) and heart (p < 0.001) tissues as well as serum 
samples (p < 0.001) when compared with the control 
group. In addition, we found that trigonelline at doses 
of 50 and 100 mg/kg significantly increased the antioxi-
dant capacity in comparison with the saline treated colitis 
group in cardiac, intestinal tissues and serum samples sig-
nificantly increased the antioxidant capacity in comparison 
with the saline-received colitis counterpart. Furthermore, 
trigonelline at the dose of 10 mg/kg significantly increased 
the antioxidant capacity of the serum sample compared 
with the saline-received colitis counterpart (p < 0.05). In 
aspect of the control counterparts, our results showed that 
trigonelline at the dose of 100 mg/kg increased the anti-
oxidant capacity in the heart tissue when compared with 
the saline-receive control counterpart (p < 0.01). Trigonel-
line at doses of 10 mg/kg (p < 0.05), 50 mg/kg (p < 0.001) 
and 100 mg/kg (p < 0.001) significantly increased the 
antioxidant capacity of the intestine tissue in comparison 
with the saline-received counterpart. Moreover, trigonel-
line at doses of 10 mg/kg (p < 0.01), 50 mg/kg (p < 0.001) 
and 100 mg/kg (p < 0.001) significantly increased the anti-
oxidant capacity of the serum samples in comparison with 
the saline-received counterpart.
Trigonelline decreased the levels of MDA in heart, 
intestine and serum samples
The MDA level of experimental colitis (the intestine 
(p < 0.01), heart (p < 0.001) tissues and serum samples 
(p < 0.001)) was significantly increased when compared 
with the control group (Fig. 3). In addition, we found that 
trigonelline at dose of 50 mg/kg [for heart (p < 0.01) and 
intestine tissue (p < 0.001) and at dose of 100 mg/kg (for 
heart (p < 0.001), intestine tissue (p < 0.001) and serum 
samples (p < 0.01)] significantly decreases the MDA level in 
comparison with the saline-received colitis counterpart. Fur-
thermore, trigonelline at the dose of 10 mg/kg significantly 
decreased the MDA level of the intestine in compared with 
the saline-received colitis counterpart (p < 0.05). Consider-
ing the control counterparts our results showed that trigonel-
line at the dose of 100 mg/kg decreased the MDA level in the 
Fig. 2  Antioxidant capacity was evaluated in the colon, heart 
and serum samples using FRAP method. Data are expressed as 
mean ± SEM and analyzed with one way ANOVA followed by tuk-
ey’s post- test. *p < 0.05, **p < 0.01 and ***p < 0.001 compared with 
the saline-received control group, #p < 0.05 and ##p < 0.01 compared 
with saline-received colitis group. TRG trigonelline
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heart tissue when compared with the saline-receive control 
counterpart (p < 0.01). Trigonelline at doses of 50 mg/kg 
(p < 0.05) and 100 mg/kg (p < 0.05) significantly decreased 
the MDA level of the intestine tissue in comparison with the 
saline-received counterpart. Moreover, trigonelline at doses 
of 10 mg/kg (p < 0.01), 50 mg/kg (p < 0.001) and 100 mg/
kg (p < 0.001) significantly decreases the MDA level of 
the serum samples in comparison with the saline-received 
counterpart.
Trigonelline decreased the expression 
of inflammatory genes of Tnf‑α, Il/1β, and Tlr4 
in the intestine and heart tissues
Experimental colitis led to a significant increase in the gene 
expression of Tnf-α (p < 0.001), Il/1β (p < 0.001) and Tlr4 
(p < 0.001) in the intestine and heart samples in comparison 
to their control groups (Fig. 4). In addition, a significant 
reduction at doses of 10 mg/kg, 50 mg/kg and 100 mg/kg 
of trigonelline for Tnf-α, Il/1β and Tlr4 in heart and in the 
intestine samples was seen when compared with the saline-
received colitis group.
Histopathological findings
We observed no significant differences among experimental 
groups in case of the histopathological scores for the extent 
of cardiac inflammation. As shown in Fig. 5, epithelial dam-
age and inflammatory cell infiltration were detected in the 
colitis group. Neutrophilic permeation to the mucosa, goblet 
cell, and crypt loss was clear, indicating colonic damage. 
The histopathological scores were significantly greater in 
the colitis group in compared to the control group (p <  0.01, 
Table 2). Moreover, trigonelline at doses of 50 (p < 0.05) 
and 100 (p < 0.01) mg/kg significantly decreased histopatho-
logical scores in comparison with the saline-received colitis 
group. However, treatment with trigonelline did not make 
significant differences in control groups when compared 
with the saline-received control counterpart.
Discussion
Findings of the present study demonstrated that experimental 
colitis significantly increased the lipid peroxidation (MDA) 
and expression of inflammatory genes as well as decreased 
the antioxidant capacity in the serum, intestine and heart 
samples. We determined that treatment with trigonelline 
significantly increased the antioxidant capacity, restores the 
MDA levels and decreased the expression of inflammatory 
genes in the intestine and heart tissues.
The interaction between the immune system with intes-
tine plays a major role in the pathophysiology of colitis 
(IBD) (Bouma and Strober 2003). Infiltration of immune 
Fig. 3  The level of MDA was evaluated in the colon, heart and serum 
samples. Data are expressed as mean ± SEM and analyzed with one 
way ANOVA followed by Tukey’s post-test. *p < 0.05, **p < 0.01 
and ***p < 0.001 compared with the saline-received control group, 
#p < 0.05, ##p < 0.01 and ###p < 0.001 compared with saline-received 
colitis group. TRG trigonelline
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Fig. 4  The expressions of inflammatory genes of Tnf-α, Il/1β and Tlr4 in the 
intestine and heart tissues were measured using RT-PCR. Data are expressed as 
relatively and analyzed with one way ANOVA followed by tukey’s post- test. 
***p < 0.001 compared with the saline-received control group, ##p < 0.01 and 
###p < 0.001 compared with saline-received colitis group. TRG trigonelline
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cells such as neutrophils and macrophages to the intestine 
tissue provokes an oxidative damage state which is com-
bined with the initiation of an inflammatory response in 
the intestine (Pavli et al. 1996). Activation of the Toll-like 
receptors (Tlr4) in the intestine results in the production of 
pro-inflammatory cytokines such as Tnf-α and Il/1β, (Laird 
et al. 2009). In this regards, it has been determined that Il/1β 
overexpression can cause disturbance of the intestinal func-
tion (Al-Sadi and Ma 2007). In addition, overexpression 
of Tnf-α increases vascular permeability and exacerbates 
inflammation. In this context, previous studies have shown 
that suppression of Tnf-α by its receptor antagonists potently 
reduced the symptoms of the IBD (Popivanova et al. 2008). 
Clinical investigations declared that immune suppressants 
such as steroids and azathioprine are effective in treatment of 
the IBD. Clinical and preclinical studies have demonstrated 
that the expression of inflammatory cytokines significantly 
increased in the bowel tissue of the IBD patients (Danese 
et al. 2005). In line with the above-mentioned studies, we 
found that the expression of Tnf-α, Il/1β and, Tlr4 signifi-
cantly increased in intestine tissue of the colitis group when 
compared with the control group.
Ample evidences showed that inflammatory bowel dis-
ease is associated with several extra-intestinal complications 
Fig. 5  Representative features of histopathologic evaluations pro-
vided from H&E-stained colon sections (×100). The normal mucus 
layer and crypts without leucocyte infiltration observed in the control 
group, while the mucosal layer with leucocyte infiltration observed in 
the colitis group (white arrow). C control group
Table 2  Histopathologic scores of the colon samples
Histopathologic changes were scored semi-quantitatively. Values are 
expressed as median and min–max (n = 8) and were analyzed using 
one-way ANOVA
**p < 0.01 compared to the control group, *p < 0.01 and ***p < 0.01 
compared to the colitis group
Group Pathologic score
Median (min–max)
Control 1 (0–2)
Control + TRG 10 mg/kg 1 (0–1)
Control + TRG 50 mg/kg 1 (0–2)
Control + TRG 100 mg/kg 1 (1–1)
Colitis 3 (3–4)**
Colitis + TRG 10 mg/kg 3 (3–3)
Colitis + TRG 50 mg/kg 2 (2–2)*
Colitis + TRG 100 mg/kg 1 (1–2)***
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including heart, eye, kidney, liver, muscle and pulmonary 
complications (Thapa et al. 2015). Growing evidences dem-
onstrated that IBD patients have a high risk of developing 
cardiovascular complications, although the exact mecha-
nisms that link cardiovascular disorders with IBD remain 
poorly understood which warranted further studies to deter-
mine the exact underlying mechanism of this comorbid-
ity (McKenzie et al. 1996). Several inflammatory markers 
which are involved in the pathophysiology of cardiovascu-
lar diseases, such as Tnf-α, IL-6, IL-18, homocysteine and 
C-reactive protein, have been identified in patients with IBD 
(Danese et al. 2005; Schicho et al. 2015). Vascular altera-
tions and coronary artery disease are common manifesta-
tions in IBD patients. Arterial wall alterations and endothe-
lial dysfunction have been observed in IBD patients, which 
increase the risk of development of atherosclerosis (Roifman 
et al. 2011; Schicho et al. 2015). It has been demonstrated 
that IBD was associated with an increased risk of hospitali-
zation for heart failure (Kristensen et al. 2014).
In this study, the lipid peroxidation level (MDA) in colon 
and heart tissues, as well as serum sample, was significantly 
higher than the control group. In addition, we found that 
the antioxidant capacity of the heart and colon tissues, as 
well as serum sample, was significantly lower than the 
control group. In case of inflammatory response, our find-
ings showed that the expression of inflammatory cytokines 
including Tnf-α, Il/1β and Tlr4 was significantly increased 
in the heart and colon tissues of the colitis group in compari-
son with the control group. Considering the aforementioned 
findings, the comorbidity between IBD and cardiovascu-
lar disorder might have represented a clue for subsequent 
IBD complications. In agreement with the previous studies 
(Amini-Khoei et al. 2016; Antoni et al. 2014; Menconi et al. 
2015; Yazbeck et al. 2011), our histopathological evalua-
tions showed that there are epithelial damage, neutrophilic 
permeation to the mucosa as well as goblet cell and crypt 
loss in the colitis group.
Several studies have reported that trigonelline exhibited 
antioxidant, anti-free radical, neuroprotective, and anti-
apoptotic effects (Yoshinari et al. 2013; Dutta et al. 2014). 
It has been shown that trigonelline has potential therapeu-
tic effects in diabetic neuropathy and reduced the levels of 
inflammatory cytokines (Zhou et al. 2012; Tohda et al. 2005; 
Gaur et al. 2013). It has also suggested that trigonelline via 
inhibition of Nrf2 transcription factor in the pancreatic can-
cer cells increases the apoptosis (Arlt et al. 2013). In addi-
tion, previous studies have demonstrated that modulation of 
the Nrf2 transcription factor exerted antioxidant properties 
(Vicente et al. 2013; Cardozo et al. 2013). Results of the 
present study showed that trigonelline effectively reduced 
the cellular/molecular and histopathological adverse effects 
of colitis in the intestine tissue. Interestingly, we showed 
that trigonelline significantly mitigated the negative effects 
of colitis on the heart tissue in which following treatment 
with trigonelline levels of the MDA and expression of 
inflammatory genes decreased in compared with the saline-
received colitis group. Furthermore, we found that trigonel-
line increased the antioxidant capacity of the heart tissue. In 
addition, we found that trigonelline significantly reversed the 
adverse effect of the colitis in serum samples.
Conclusion
Overall, findings of the present study demonstrated that, in 
part at least, trigonelline via attenuation of oxidative stress 
(decrease in the MDA level and increase in the antioxidant 
capacity), as well as mitigation of inflammatory response, 
decreased the histopathological and cellular adversative 
effects of experimental colitis in the colon and heart tissues. 
Our results provide indicators that IBD (colitis) is associated 
with cellular/molecular alterations in the heart and for the 
first time, we found that trigonelline has potential therapeu-
tic effects to attenuate the colitis signs as well as probable 
cardiac complications.
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